Business Formation Contracts & Agreements in the Biotechnology Industry
179 Contracts & Agreements
- Articles of Amendment (123 contracts from 56 companies)
- Articles of Association (6 | 3)
- Articles of Incorporation (19 | 15)
- Limited Liability Company Agreements (29 | 20)
- Limited Partnership Agreements (2 | 1)
- Acurx Pharmaceuticals, LLC (1 contract)
- Advaxis, Inc. (1)
- AgeX Therapeutics, Inc. (3)
- ALBIREO PHARMA, INC. (2)
- Allarity Therapeutics, Inc. (1)
- ALNYLAM PHARMACEUTICALS, INC. (2)
- ARCA biopharma, Inc. (1)
- Athenex, Inc. (2)
- ATOSSA GENETICS INC (2)
- BioCardia, Inc. (1)
- BIOCRYST PHARMACEUTICALS INC (1)
- BIOMARIN PHARMACEUTICAL INC (1)
- Blue Water Vaccines Inc. (1)
- BridgeBio Pharma, Inc. (2)
- CALADRIUS BIOSCIENCES, INC. (1)
- Calyxt, Inc. (1)
- CANCER GENETICS, INC (1)
- Capstone Therapeutics Corp. (6)
- Cellectar Biosciences, Inc. (7)
- Checkpoint Therapeutics, Inc. (1)
- Consonance-HFW Acquisition Corp. (1)
- CTI BIOPHARMA CORP (2)
- Cullinan Oncology, LLC (1)
- Cybrdi, Inc. (1)
- Diffusion Pharmaceuticals Inc. (6)
- Edge Therapeutics, Inc. (1)
- ENDONOVO THERAPEUTICS, INC. (1)
- ENZON PHARMACEUTICALS, INC. (1)
- ESSA Pharma Inc. (2)
- Fibrocell Science, Inc. (2)
- Flex Pharma, Inc. (1)
- Gamida Cell Ltd. (3)
- GENELUX CORP (1)
- GENETHERA INC (1)
- GeoVax Labs, Inc. (2)
- Gilead Sciences (2)
- Graphite Bio, Inc. (1)
- Greater Cannabis Company, Inc. (1)
- GT Biopharma, Inc. (1)
- HARBOR DIVERSIFIED, INC. (1)
- Homology Medicines, Inc. (1)
- iBio, Inc. (2)
- IDERA PHARMACEUTICALS, INC. (1)
- Immune Therapeutics, Inc. (1)
- ImmunoCellular Therapeutics, Ltd. (1)
- International Stem Cell CORP (5)
- INTREXON CORP (2)
- IONIS PHARMACEUTICALS INC (2)
- KBL MERGER CORP. IV (1)
- KIWA BIO-TECH PRODUCTS GROUP CORP (1)
- LA JOLLA PHARMACEUTICAL CO (2)
- LONGEVERON LLC (2)
- MANHATTAN SCIENTIFICS INC (1)
- Medovex Corp. (2)
- Merus N.V. (1)
- MYMETICS CORP (2)
- NANOVIRICIDES, INC. (17)
- NAVIDEA BIOPHARMACEUTICALS, INC. (4)
- Nuo Therapeutics, Inc. (2)
- ORAGENICS INC (2)
- Organicell Regenerative Medicine, Inc. (1)
- Orgenesis Inc. (3)
- PharmaCyte Biotech, Inc. (1)
- PIERIS PHARMACEUTICALS, INC. (1)
- PLURISTEM THERAPEUTICS INC (3)
- POLARITYTE, INC. (8)
- PROGENITY, INC. (2)
- Propanc Biopharma, Inc. (1)
- Regeneron Pharmaceuticals (1)
- Replimune Group, Inc. (1)
- Seres Therapeutics, Inc. (1)
- Social Capital Suvretta Holdings Corp. III (2)
- Solid Biosciences Inc. (1)
- Spectrum Pharmaceuticals, Inc. (4)
- SPHERIX INC (6)
- TENAX THERAPEUTICS, INC. (6)
- Transcode Therapeutics, Inc. (1)
- uniQure N.V. (1)
- UroGen Pharma Ltd. (2)
- USA EQUITIES CORP. (1)
- Vericel Corp (3)
- Virios Therapeutics, LLC (3)
- vTv Therapeutics Inc. (2)
- Zentalis Pharmaceuticals, LLC (2)
Recent Contracts
Category
Company
Industry
Jur.
Filed
Biotechnology
DE
2025
Biotechnology
2025
Biotechnology
2025
Biotechnology
2025
Biotechnology
DE
2024
Biotechnology
DE
2024
Biotechnology
2024
Biotechnology
DE
2024
Biotechnology
NV
2024
Biotechnology
2024
Biotechnology
NY
2024
Biotechnology
NY
2024
Biotechnology
2024
Biotechnology
2024
Biotechnology
NY
2024
Biotechnology
DE
2023
Biotechnology
2023
Biotechnology
DE
2023
Biotechnology
DE
2023
Biotechnology
2023
Biotechnology
DE
2023
Biotechnology
DE
2023
Biotechnology
2023
Biotechnology
DE
2023
Biotechnology
2023
Biotechnology
DE
2022
Biotechnology
NY
2022
Biotechnology
DE
2022
Biotechnology
2022
Biotechnology
DE
2022
Biotechnology
2022
Biotechnology
2021
Biotechnology
DE
2021
Biotechnology
2021
Biotechnology
2021
Biotechnology
2021
Biotechnology
DE
2021
Biotechnology
2021
Biotechnology
2021
